Search results
Results from the WOW.Com Content Network
North American people associated with ghost sickness include the Navajo and some Muscogee and Plains cultures. In the Muscogee (Creek) culture, it is believed that everyone is a part of an energy called Ibofanga. This energy supposedly results from the flow between mind, body, and spirit. Illness can result from this flow being disrupted.
Bone marrow syndrome, gastrointestinal syndrome, neurovascular syndrome [1] [3] Causes: Large amounts of ionizing radiation over a short period of time [1] Diagnostic method: Based on history of exposure and symptoms [4] Treatment: Supportive care (blood transfusions, antibiotics, colony stimulating factors, stem cell transplant) [3] Prognosis
A sickness which is contracted from prolonged proximity with ghosts, which causes hallucinations, fever, chills and extreme fear. Dean Winchester contracted this disease from an evil ghost he encountered and became immensely afraid of every single thing he encountered, even being afraid of a cat. The vanquishing of the ghost defeated the disease.
This belief in hóchxǫ́, translated as "chaos" or "sickness", is the opposite of hózhǫ́ and helps to explain why people, who are intended to be in harmony, perform actions counter to their ideals, thus reinforcing the need for healing practices as means of balance and restoration. Those who practice witchcraft include shape shifters who ...
A radiation sickness treatment with psychedelic side-effects. Pyrholidon has the same chemical structure as the real drug AEOL-10150. AEOL-10150 is a drug in development designed to treat sulfur mustard and nerve agent exposure, as well as pneumonitis due to acute radiation syndrome. [64]
Iich'aa (Navajo: Iichʼąh, [1] pronounced “eech aaw”, no inflexion [2]) is a culture-bound syndrome found in the Navajo Native American culture. Symptoms include epileptic behaviour (nervousness, convulsions), loss of self-control, self-destructive behaviour and fits of violence and rage.
Human infectious diseases may be characterized by their case fatality rate (CFR), the proportion of people diagnosed with a disease who die from it (cf. mortality rate).It should not be confused with the infection fatality rate (IFR), the estimated proportion of people infected by a disease-causing agent, including asymptomatic and undiagnosed infections, who die from the disease.
As such, the Cotard's syndrome patient presents a greater incidence of brain atrophy—especially of the median frontal lobe—than do people in control groups. [18] Cotard's syndrome also has resulted from a patient's adverse physiological response to a drug (e.g., acyclovir) and to its prodrug precursor (e.g., valaciclovir).